What is the price-to-earnings ratio of Li Kang Biomedical Co?
The price-earnings ratio of Li Kang Biomedical Co is currently 16.47.
Li Kang Biomedical Co P/E 2024
Li Kang Biomedical Co P/E
16.47
Ticker
6242.TWO
ISIN
TW0006242001
As of Jun 18, 2024, Li Kang Biomedical Co's P/E ratio was 16.47, a 51.66% change from the 10.86 P/E ratio recorded in the previous year.
The Li Kang Biomedical Co P/E history
Li Kang Biomedical Co Aktienanalyse
What does Li Kang Biomedical Co do?
Li Kang Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Li Kang Biomedical Co's P/E Ratio
The Price to Earnings (P/E) Ratio of Li Kang Biomedical Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Li Kang Biomedical Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Li Kang Biomedical Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Li Kang Biomedical Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Li Kang Biomedical Co Stock
How has the price-earnings ratio of Li Kang Biomedical Co changed compared to last year?
The price-to-earnings ratio of Li Kang Biomedical Co has increased by 51.66% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Li Kang Biomedical Co high compared to other companies?
Yes, the price-to-earnings ratio of Li Kang Biomedical Co is high compared to other companies.
How does an increase in the price-earnings ratio of Li Kang Biomedical Co affect the company?
An increase in the price-earnings ratio of Li Kang Biomedical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Li Kang Biomedical Co affect the company?
A decrease in the price-earnings ratio of Li Kang Biomedical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Li Kang Biomedical Co?
Some factors that influence the price-earnings ratio of Li Kang Biomedical Co are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Li Kang Biomedical Co pay?
Over the past 12 months, Li Kang Biomedical Co paid a dividend of 1.74 TWD . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Li Kang Biomedical Co is expected to pay a dividend of 1.74 TWD.
What is the dividend yield of Li Kang Biomedical Co?
The current dividend yield of Li Kang Biomedical Co is 3.42 %.
When does Li Kang Biomedical Co pay dividends?
Li Kang Biomedical Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Li Kang Biomedical Co?
Li Kang Biomedical Co paid dividends every year for the past 2 years.
What is the dividend of Li Kang Biomedical Co?
For the upcoming 12 months, dividends amounting to 1.74 TWD are expected. This corresponds to a dividend yield of 3.42 %.
In which sector is Li Kang Biomedical Co located?
Li Kang Biomedical Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Li Kang Biomedical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Li Kang Biomedical Co from 7/26/2024 amounting to 2.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.
When did Li Kang Biomedical Co pay the last dividend?
The last dividend was paid out on 7/26/2024.
What was the dividend of Li Kang Biomedical Co in the year 2023?
In the year 2023, Li Kang Biomedical Co distributed 1.242 TWD as dividends.
In which currency does Li Kang Biomedical Co pay out the dividend?
The dividends of Li Kang Biomedical Co are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Li Kang Biomedical Co
Our stock analysis for Li Kang Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Li Kang Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Li Kang Biomedical Co Revenue
- Li Kang Biomedical Co Net Income
- Li Kang Biomedical Co P/E
- Li Kang Biomedical Co P/S
- Li Kang Biomedical Co EBIT
- Li Kang Biomedical Co Dividend
- Li Kang Biomedical Co Stocks
- Li Kang Biomedical Co Market capitalization
- Li Kang Biomedical Co Debt
- Li Kang Biomedical Co Liabilities
- Li Kang Biomedical Co Equity
- Li Kang Biomedical Co AAQS
- Li Kang Biomedical Co Employees
- Li Kang Biomedical Co ROE
- Li Kang Biomedical Co ROA
- Li Kang Biomedical Co ROCE